Epstein-Barr virus (EBV) establishes a latent, life-long infection in more than 95% of the human adult population. Antigen-specific, cytolytic T lymphocytes (CTLs) are thought to be of central importance in controlling EBV in both primary and latent infection states. While a good deal is known about
No takes yet. Share an insight, caveat, or question.
Miles et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: